Acute Invasive Aspergillosis Treatment Market
According to Intent Market Research, the Acute Invasive Aspergillosis Treatment Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 5.7% to touch USD 3.1 billion by 2030. The Acute Invasive Aspergillosis Treatment Market is dominated by key players such as, Astellas Pharma Inc., Amphastar Pharmaceuticals, Inc., Cipla Inc., Novartis AG, and F. Hoffmann-La Roche Ltd.